Long non-coding RNAs in cancer: implications for personalized therapy M Vitiello, A Tuccoli, L Poliseno Cellular oncology 38, 17-28, 2015 | 111 | 2015 |
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells M Vitiello, A Tuccoli, R D’Aurizio, S Sarti, L Giannecchini, S Lubrano, ... Oncotarget 8 (15), 25395, 2017 | 75 | 2017 |
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma M Vitiello, M Evangelista, N Di Lascio, C Kusmic, A Massa, F Orso, S Sarti, ... Oncogene 38 (19), 3756-3762, 2019 | 41 | 2019 |
The landscape of BRAF transcript and protein variants in human cancer A Marranci, Z Jiang, M Vitiello, E Guzzolino, L Comelli, S Sarti, S Lubrano, ... Molecular Cancer 16, 1-25, 2017 | 37 | 2017 |
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response I Barravecchia, S Mariotti, A Pucci, F Scebba, C De Cesari, S Bicciato, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (9 …, 2019 | 25 | 2019 |
Biological role of miR-204 and miR-211 in melanoma M Vitiello, R D’Aurizio, L Poliseno Oncoscience 5 (7-8), 248, 2018 | 19 | 2018 |
PTENP1 is a ceRNA for PTEN: it’s CRISPR clear M Vitiello, M Evangelista, Y Zhang, L Salmena, PP Pandolfi, L Poliseno Journal of Hematology & Oncology 13, 1-5, 2020 | 16 | 2020 |
Kidins220/ARMS interacts with Pdzrn3, a protein containing multiple binding domains M Andreazzoli, G Gestri, E Landi, B D’Orsi, M Barilari, A Iervolino, ... Biochimie 94 (9), 2054-2057, 2012 | 15 | 2012 |
Identification of BRAF 3'UTR isoforms in melanoma A Marranci, A Tuccoli, M Vitiello, E Mercoledi, S Sarti, S Lubrano, ... The Journal of investigative dermatology 135 (6), 1694-1697, 2015 | 14 | 2015 |
Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model F Finamore, N Ucciferri, G Signore, A Cecchettini, E Ceccherini, M Vitiello, ... Talanta 220, 121381, 2020 | 11 | 2020 |
Kidins220/ARMS is dynamically expressed during Xenopus laevis development S Marracci, M Giannini, M Vitiello, M Andreazzoli, L Dente Int J Dev Biol 57 (9-10), 787-792, 2013 | 9 | 2013 |
GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma M Scatolini, A Patel, E Grosso, M Mello‐Grand, P Ostano, R Coppo, ... British Journal of Dermatology 186 (1), 117-128, 2022 | 8 | 2022 |
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system A Corrado, R Aceto, R Silvestri, I Dell'Anno, B Ricci, S Miglietta, C Romei, ... Thyroid 31 (7), 1056-1066, 2021 | 7 | 2021 |
An immunocompetent environment unravels the proto-oncogenic role of miR-22 ML Centomo, M Vitiello, L Poliseno, PP Pandolfi Cancers 14 (24), 6255, 2022 | 6 | 2022 |
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells E Barresi, C Baldanzi, M Roncetti, M Roggia, E Baglini, I Lepori, M Vitiello, ... European Journal of Medicinal Chemistry 256, 115446, 2023 | 4 | 2023 |
PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation A Marranci, A Prantera, S Masotti, R De Paolo, C Baldanzi, MS Podda, ... Journal of Hematology & Oncology 16 (1), 33, 2023 | 4 | 2023 |
A network of MicroRNAs and mRNAs involved in melanosome maturation and trafficking defines the lower response of pigmentable melanoma cells to targeted therapy M Vitiello, A Mercatanti, MS Podda, C Baldanzi, A Prantera, S Sarti, ... Cancers 15 (3), 894, 2023 | 4 | 2023 |
Methods for the identification of PTEN-targeting microRNAs A Tuccoli, M Vitiello, A Marranci, F Russo, L Poliseno PTEN: Methods and Protocols, 111-138, 2016 | 4 | 2016 |
CRISPR/Cas Technologies Applied to Pseudogenes M Vitiello, L Poliseno Pseudogenes: Functions and Protocols, 265-284, 2021 | 3 | 2021 |
In vivo silencing/overexpression of lncRNAs by CRISPR/Cas system M Vitiello, L Poliseno, PP Pandolfi Long Non-Coding RNAs in Cancer, 205-220, 2021 | 3 | 2021 |